NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Aurora Biomed, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aurora Biomed, Inc. Launches New Line of Water Purification Systems - Aurora's Crysta Series - Pure water for better science - AuroraBiomed.com
Aurora Biomed, Inc. Launches New Line of Water Purification Systems

 

NewswireToday - /newswire/ - Vancouver, British Columbia, Canada, 2009/02/24 - Aurora's Crysta Series - Pure water for better science - AuroraBiomed.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Aurora Biomed, Inc., a leading developer of solutions for life science, analytical and drug discovery research, is adding a new series of laboratory water purification systems to complement its existing line of high precision instruments. The Crysta Series is a high quality water purification system that will produce better technical results for even the most demanding scientific applications.

The Crysta 500, 1000, and 2000 systems serve three different areas of scientific applications. These applications range from general pure water use in buffer preparation and high purity glassware rinsing to critical use in high performance liquid chromatography and polymerase chain reactions. Aurora’s Crysta Series produces highly purified lab water that meets ASTM and CLSI clinical laboratory standards. All three models use unique networks of filtration systems developed to produce the highest quality Type 1 and Type 2 pure water. The Crysta 500 uses a 6 step filtration system to purify tap water into reverse osmosis water and then into even purer Type 2 deionized water. The Crysta 1000 system produces Type 1 ultrapure analytical water using Ultrapure Polishing Cartridges. The Crysta 2000 system uses advanced 5000 Doulton Ultrafilters and Double Wavelength Ultraviolet Lamps to produce the purest Type 1 water for use in critical PCR and HPLC applications.

The Crysta Series uses unique filtration networks to consistently deliver high quality pure lab water for better technical results. With special features such as walk-away unattended operation, real time display of purity levels, and innovative cartridge monitoring systems, the Crysta Series is a dependable, high quality and high performance laboratory water purification system that will meet and surpass the demands of any pure water needs.

About Aurora

Aurora Biomed, Inc. (aurorabiomed.com) provides enabling technologies for drug discovery research, analytical chemistry and laboratory automation. Aurora develops the VERSA™ liquid-handling workstations for greater efficiency and higher data quality in PCR and Nucleic Acid Prep, as well as the Atomic Absorption Spectrometers and Microwave Digestion Systems. Aurora Biomed hosts the annual Ion Channel Retreat for scientific discourse on ion channel disciplines and is headquartered in Vancouver, BC, Canada, with global sales, support and service offices.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Aurora Biomed, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Aurora Biomed, Inc. Launches New Line of Water Purification Systems

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Clarence Chew - AuroraBiomed.com 
1-800-883-2918 info[.]aurorabiomed.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Aurora Biomed, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Aurora Biomed, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Health Canada Approves Ipsen’s Sohonos (Palovarotene Capsules) as the First Approved Treatment for Fibrodysplasia Ossificans Progressiva
LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
PharmaEssentia Selects Veeva Data Cloud to Support Launch of Novel Therapy for Rare, Chronic Blood Cancers
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050 - A Novel Individualized Neoantigen Cancer Vaccine
DSM Plans New Production Site for Bovaer® in Dalry, Scotland
Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  Limelon Advertising, Co.





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)